Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Clene Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 24 | 29 | +5 |
| Shares | 582.1K | 783.8K | +201.7K (+34.6%) |
| Value | $2.28M | $4.72M | +$2.45M (+107.4%) |
New holders (9)
Institutions that held Clene Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 30,440 | $183.4K | 0.00% |
| Marshall Wace, LLP | 22,709 | $136.9K | 0.00% |
| Ensign Peak Advisors, Inc | 14,880 | $89.7K | 0.00% |
| Jones Financial Companies LLLP | 5,000 | $29.4K | 0.00% |
| Wells Fargo & Company | 4,247 | $25.6K | 0.00% |
| The PNC Financial Services Group, Inc. | 2,735 | $16.5K | 0.00% |
| Principal Securities, Inc. | 15 | $90 | 0.00% |
| FMR LLC | 1 | $6 | 0.00% |
| Citigroup Inc | 1 | $6 | 0.00% |
Sold out (4)
Institutions that held Clene Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Jane Street Group, LLC | 12,095 | $47.3K |
| JPMorgan Chase & Co | 1,276 | $4.99K |
| Tower Research Capital LLC (TRC) | 1,153 | $4.51K |
| Raymond James Financial Inc | 35 | $137 |